These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 3950464

  • 1. Spironolactone therapy for hyperandrogenic anovulatory women--clinical and endocrinological study.
    Masahashi T, Wu MC, Ohsawa M, Asai M, Ichikawa Y, Hanai K, Kikkawa H, Mizutani S, Narita O, Tomoda Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):95-101. PubMed ID: 3950464
    [Abstract] [Full Text] [Related]

  • 2. Induction of ovulation with spironolactone (Aldactone) in anovulatory oligomenorrheic and hyperandrogenic women.
    Evron S, Shapiro G, Diamant YZ.
    Fertil Steril; 1981 Oct; 36(4):468-71. PubMed ID: 6793406
    [Abstract] [Full Text] [Related]

  • 3. Role of sex-hormone-binding globulin and free sex steroid hormones in hyperandrogenic anovulation.
    Ohsawa M, Asai M, Masahashi T, Narita O, Tomoda Y, Matsui N.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2081-8. PubMed ID: 2947958
    [Abstract] [Full Text] [Related]

  • 4. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Nov; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 5. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
    Venturoli S, Porcu E, Gammi L, Fabbri R, Paradisi R, Flamigni C, Patrono D, Capelli M, Paoletti C.
    Acta Eur Fertil; 1988 Nov; 19(3):129-34. PubMed ID: 2976224
    [Abstract] [Full Text] [Related]

  • 6. Serum testosterone, dihydrotestosterone and sex hormone binding globulin (SHBG) in girls with hirsutism and menstrual disturbances).
    Szamatowicz M, Kulikowski M.
    Endokrinologie; 1979 Feb; 73(1):20-6. PubMed ID: 572765
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effects of spironolactone in polycystic ovary syndrome.
    Milewicz A, Silber D, Kirschner MA.
    Obstet Gynecol; 1983 Apr; 61(4):429-32. PubMed ID: 6828272
    [Abstract] [Full Text] [Related]

  • 8. Effects and side-effects of spironolactone therapy in women with acne.
    Yemisci A, Gorgulu A, Piskin S.
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):163-6. PubMed ID: 15752283
    [Abstract] [Full Text] [Related]

  • 9. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R, Hirvensalo E, Liukko P, Malmiharju T, Mattila L, Riihiluoma P, Ylöstalo P.
    Acta Derm Venereol; 1984 Mar; 64(6):517-23. PubMed ID: 6084924
    [Abstract] [Full Text] [Related]

  • 10. Induction of LH surge with estradiol benzoate and its clinical significance in anovulatory women.
    Kusuda M, Onoue T.
    Int J Fertil; 1982 Mar; 27(4):198-205. PubMed ID: 6131037
    [Abstract] [Full Text] [Related]

  • 11. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M.
    Acta Univ Palacki Olomuc Fac Med; 1989 Mar; 122():239-45. PubMed ID: 2530821
    [Abstract] [Full Text] [Related]

  • 12. Assessment of androgens in women with adult-onset acne.
    Seirafi H, Farnaghi F, Vasheghani-Farahani A, Alirezaie NS, Esfahanian F, Firooz A, Ghodsi SZ.
    Int J Dermatol; 2007 Nov; 46(11):1188-91. PubMed ID: 17988341
    [Abstract] [Full Text] [Related]

  • 13. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E, Lobo RA.
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [Abstract] [Full Text] [Related]

  • 14. Effects of unkei-to, an herbal medicine, on endocrine function and ovulation in women with high basal levels of luteinizing hormone secretion.
    Ushiroyama T, Ikeda A, Sakai M, Hosotani T, Suzuki Y, Tsubokura S, Ueki M.
    J Reprod Med; 2001 May; 46(5):451-6. PubMed ID: 11396371
    [Abstract] [Full Text] [Related]

  • 15. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
    Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Sorge R, Raskovic D.
    Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
    [Abstract] [Full Text] [Related]

  • 16. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
    Ho Yuen B, Mincey EK.
    Am J Obstet Gynecol; 1983 Jan 15; 145(2):152-7. PubMed ID: 6401396
    [Abstract] [Full Text] [Related]

  • 17. [Changes in serum androgen levels in patients with polycystic ovary syndrome].
    Yoshino K, Takahashi K, Nishigaki A, Eda Y, Kitao M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep 15; 43(9):1214-8. PubMed ID: 1919182
    [Abstract] [Full Text] [Related]

  • 18. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug 15; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 19. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A, Agarwal N.
    J Reprod Med; 2004 May 15; 49(5):361-7. PubMed ID: 15214709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.